Skip Navigation


Annals of Oncology Advance Access originally published online on June 6, 2008
Annals of Oncology 2008 19(8):1509-1510; doi:10.1093/annonc/mdn390
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
19/8/1509-a    most recent
mdn390v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ring, A.
Right arrow Articles by Webb, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ring, A.
Right arrow Articles by Webb, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

letters to the editors

Infusion of trastuzumab maintenance doses over 30 minutes

The first 10% of the full text of this article appears below.

The humanized monoclonal antibody trastuzumab is licensed for both the adjuvant treatment of early breast cancer and the palliation of metastatic breast cancer [1]. In the UK, trastuzumab is usually administered on a three weekly schedule. According to the license, it is infused over a period of 90 . . . [Full Text of this Article]

A. Ring1,2,*, R. Simcock1, S. Mitra3, D. Bloomfield1, J. King1, S. Simpson3, G. Sadler4 and A. Webb1

1 Sussex Cancer Centre, Royal Sussex County Hospital, Brighton
2 Eastbourne District General Hospital, Eastbourne
3 Worthing Hospital, Worthing, West Sussex
4 Conquest Hospital, St Leonards on Sea, UK

* (E-mail: alistair.ring@bsuh.nhs.uk)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?